Approval · Notice of Compliance 24110 · 2020
EPURIS: Notice of Compliance 24110
Issued August 26, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24110
- Date
- August 26, 2020
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To make revisions to cartons and package insert and to stregnthen the wording and risk minimization measures regarding rhabdomyolysis
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EPURIS | Not yet assigned | — |
Medicinal ingredients
- ISOTRETINOIN 10 MG per CAP
- ISOTRETINOIN 20 MG per CAP
- ISOTRETINOIN 30 MG per CAP
- ISOTRETINOIN 40 MG per CAP